The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment.
about
18 F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)Harmonized diagnostic criteria for Alzheimer's disease: recommendationsA window into the heterogeneity of human cerebrospinal fluid Aβ peptidesAlliance for aging research AD biomarkers work group: structural MRI.Recent advances in imaging Alzheimer's disease.Neuroimaging measures as endophenotypes in Alzheimer's diseaseVolume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study.Structural MRI and Amyloid PET Imaging for Prediction of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis.Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.Dementia and behavioral neurology: recent advances.EFNS task force: the use of neuroimaging in the diagnosis of dementia.CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Supporting evidence for using biomarkers in the diagnosis of MCI due to AD.Alzheimer's disease Archimedes condition-event simulator: Development and validation.Translation of imaging biomarkers from clinical research to healthcare.Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment.Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use.
P2860
Q24186399-BF57FDE4-EEEE-48D2-9B08-4D1EB699CA4BQ24193707-CA3CFFD4-227E-46D5-8495-F7ACF7B1DD34Q27009157-B15DC2E6-5540-475C-AD1A-07C0BCF267A7Q27010785-EA273700-63DD-4E04-A3A9-F0B23904BD72Q27692607-BF7AE312-3AB0-4C40-93E9-A7896975D7DBQ33946440-10606E0E-C157-44E2-A42E-406107E44F46Q34924165-762742AA-5BCA-493B-A05F-B232C29D46F4Q34988405-663E6051-5124-403F-A3C0-C8A4CEDE4D06Q37706441-A22F6E86-4D87-4C82-B4DC-B828D6DE7976Q37895052-84F63B14-9397-46B7-88C0-BCF5E722FF9AQ38004863-49D2CFE4-8293-4216-94DE-03D16D046E70Q38035398-4CEAA9F5-95F3-4C78-AE60-A7AB7E58BE5EQ38741683-5B48DD2B-4EFC-4098-9B40-B4BBF4837AE0Q45178246-D82FCD37-C062-4652-874B-D3129A680E9BQ52568119-2F1EBCEB-3935-408D-9ACD-A1E9ED26D928Q52881521-4CCE3432-866B-428E-AFEB-37E8C74372B9Q53145536-99732E39-CC0B-44EA-8478-97CA8515DE70Q53427571-9F8D5588-D351-4322-A005-35813DAB25BF
P2860
The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@en
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@nl
type
label
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@en
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@nl
prefLabel
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@en
The new Alzheimer's criteria i ...... ith mild cognitive impairment.
@nl
P2093
P2860
P50
P1433
P1476
The new Alzheimer's criteria i ...... with mild cognitive impairment
@en
P2093
Translational Outpatient Memory Clinic Working Group
P2860
P2888
P304
P356
10.1007/S00415-010-5650-0
P50
P577
2010-07-15T00:00:00Z